InfuSystem Holdings, Inc. (INFU)
NYSEAMERICAN: INFU · Real-Time Price · USD
14.35
+0.29 (2.06%)
Nov 20, 2026, 4:00 PM EST - Market closed
InfuSystem Holdings Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 9.11 | 3.19 | 0.53 | 0.23 | 0.17 | 0.19 |
Cash & Short-Term Investments | 9.11 | 3.19 | 0.53 | 0.23 | 0.17 | 0.19 |
Cash Growth | 853.72% | 504.55% | 128.14% | 40.00% | -11.29% | -98.07% |
Receivables | 30.54 | 24.15 | 21.73 | 21.1 | 17.23 | 15.41 |
Inventory | 5.15 | 5.39 | 6.53 | 6.4 | 4.82 | 3.94 |
Other Current Assets | 3.12 | 3.61 | 3.39 | 2.89 | 2.56 | 2.54 |
Total Current Assets | 47.91 | 36.34 | 32.17 | 30.62 | 24.78 | 22.07 |
Property, Plant & Equipment | 39.52 | 41.99 | 48.58 | 45.95 | 48 | 48.64 |
Long-Term Investments | 0.91 | 0.75 | 1.48 | 1.44 | 1.97 | 0.36 |
Goodwill | 3.71 | 3.71 | 3.71 | 3.71 | 3.71 | 3.71 |
Other Intangible Assets | 6.32 | 6.87 | 6.46 | 7.45 | 8.44 | 10.93 |
Long-Term Accounts Receivable | 1.04 | 1.34 | 0.73 | 1.52 | - | - |
Long-Term Deferred Tax Assets | 2.17 | 4.64 | 7.19 | 9.12 | 9.63 | 10.03 |
Other Long-Term Assets | 2.94 | 4.93 | 3.31 | 3.11 | 2.87 | 1.86 |
Total Assets | 104.52 | 100.56 | 103.61 | 102.92 | 99.39 | 97.59 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 9.95 | 10.82 | 9.85 | 8.01 | 8.34 | 7.86 |
Accrued Expenses | - | 5.5 | 4.8 | 4.6 | 3.3 | 1.3 |
Current Portion of Long-Term Debt | - | - | - | - | - | 0.35 |
Current Portion of Leases | 1.38 | 1.39 | - | - | - | - |
Other Current Liabilities | 6.55 | 2.47 | 3.01 | 3.1 | 2.83 | 3.39 |
Total Current Liabilities | 17.87 | 20.18 | 17.66 | 15.71 | 14.47 | 12.9 |
Long-Term Debt | 19.69 | 19.63 | 23.86 | 29.1 | 33.16 | 32.75 |
Long-Term Leases | 2.81 | 3.43 | 4.56 | 5.8 | 3.76 | 3.67 |
Total Liabilities | 40.37 | 43.23 | 46.09 | 50.61 | 51.39 | 49.31 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 121.73 | 117.46 | 113.87 | 109.84 | 105.86 | 101.91 |
Retained Earnings | -58.26 | -60.7 | -57.46 | -58.63 | -59.34 | -53.9 |
Comprehensive Income & Other | 0.68 | 0.57 | 1.12 | 1.09 | 1.49 | 0.27 |
Shareholders' Equity | 64.15 | 57.33 | 57.53 | 52.3 | 48 | 48.27 |
Total Liabilities & Equity | 104.52 | 100.56 | 103.61 | 102.92 | 99.39 | 97.59 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 23.88 | 24.44 | 28.42 | 34.9 | 36.92 | 36.77 |
Net Cash (Debt) | -14.77 | -21.25 | -27.9 | -34.67 | -36.75 | -36.58 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.70 | -1.01 | -1.29 | -1.60 | -1.71 | -1.66 |
Filing Date Shares Outstanding | 20.03 | 20.22 | 21.01 | 21.26 | 20.89 | 20.55 |
Total Common Shares Outstanding | 20.03 | 20.21 | 21.27 | 21.2 | 20.78 | 20.7 |
Working Capital | 30.04 | 16.15 | 14.5 | 14.91 | 10.31 | 9.17 |
Book Value Per Share | 3.20 | 2.84 | 2.70 | 2.47 | 2.31 | 2.33 |
Tangible Book Value | 54.12 | 46.75 | 47.36 | 41.15 | 35.86 | 33.63 |
Tangible Book Value Per Share | 2.70 | 2.31 | 2.23 | 1.94 | 1.73 | 1.62 |
Machinery | 119.13 | 112.76 | 110.77 | 100.87 | 102.69 | 95.74 |
Leasehold Improvements | 5.14 | 5.1 | 4.91 | 3.57 | 3.5 | 3.44 |